Furthermore, receiver operating characteristic curve (ROC curve) analysis indicated that SCD5 could be a good predictor of pCR in patients with breast cancer, especially in TNBC (Fig. 5A, Table 1, p < 0.05). However, there was no significant correlation between SCD1 expression and chemotherapy response (Figure S4). This evidence concerns the gene SCD and breast carcinoma.